city New Delhi India covid-19 infection patient city New Delhi India

Zydus Cadila gets DCGI nod to repurpose hepatitis drug to treat covid-19

Reading now: 481
www.livemint.com

NEW DELHI: Zydus Cadila today announced that its has received restricted emergency use approval from the Drugs Controller General of India (DCGI) V.G.

Somani for the use of ‘Virafin’, a pegylated interferon alpha-2b (PegIFN), to treat moderate covid-19 infection in adults.The drug was originally used in treatment against hepatitis B and C, and is administered in a single dose subcutaneous regimen.The company said that when administered early on during covid-19, Virafin can help patients recover faster and avoid much of the complications.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA